News

Elis Reports on Share Capital and Voting Rights Update

Elis Reports on Share Capital and Voting Rights Update

Overview of Share Capital and Voting Rights

Elis has recently provided a significant update concerning its share capital and voting rights. These figures are vital for both investors and stakeholders, as they offer insight into the company's financial health. This information is shared in accordance with legal requirements, ensuring transparency in Elis's operations.

Current Share Capital Details

As of the most recent reporting period, the total number of shares that constitute the share capital is 235,567,817. This figure gives investors a clear understanding of the company's equity structure.

Theoretical Voting Rights

Alongside shares, the theoretical number of voting rights is reported to be 267,565,661. This number is significant for shareholders, as it reflects the potential influence they wield in corporate governance and decision-making processes.

Exercisable Voting Rights

Regarding exercisable voting rights, the current figure is 267,512,953. This represents the voting power that shareholders can actively utilize during corporate meetings, thus affecting strategic decisions.

Importance of Disclosure

This disclosure underscores Elis's commitment to transparency and adherence to regulatory standards. It serves as a valuable resource for both current and prospective investors, ensuring they have access to essential information needed for informed decision-making.

Contact Information for Investor Relations

For further details and inquiries, investors can reach out to the following contacts:

Nicolas Buron, Director of Investor Relations, Financing & Treasury
Phone: +33 1 75 49 98 30 - Email: nicolas.buron@elis.com

Charline Lefaucheux, Investor Relations
Phone: +33 1 75 49 98 15 - Email: charline.lefaucheux@elis.com

Frequently Asked Questions

What is the total number of shares for Elis?

The total number of shares that make up the capital is 235,567,817.

How many theoretical voting rights does Elis have?

Elis has a theoretical total of 267,565,661 voting rights.

What are exercisable voting rights?

Exercisable voting rights refer to the voting power that shareholders can actively use, which currently amounts to 267,512,953.

Why is this disclosure important?

This disclosure is crucial for maintaining transparency and providing stakeholders with essential information regarding the company's governance.

Who can I contact for investor relations?

You can reach out to Nicolas Buron or Charline Lefaucheux for any investor-related inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 25

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 174

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
Curaleaf Eyes Aurora Amid Alternative from Organigram

Updated Category News Views 65

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 123

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Updated Category News Views 64

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Continue Reading
Class Action Targets Coastal Financial Over Missteps

Updated Category News Views 32

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 86

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 22

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Multiconsult's Q3 2026 Results: A Gradual Rebound

Updated Category News Views 30

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...

Continue Reading

Top 5 Most Recently Viewed Articles

Bittium Wireless Ltd Partners with Indra Group for SDR Tech

Updated Category News Views 148

Bittium Wireless Ltd Partners with Indra Group Bittium Wireless Ltd, a subsidiary of Bittium Corporation, has formed a significant partnership with the Spanish Indra Group for the licensing of its advanced Tough SDR technology. Indra has made an initial purchase order valued at EUR 50 million, demonstrating the firm’s commitment to enhancing its tactical communication...

Continue Reading
Major Milestone Achieved as Amaroq Minerals Pours First Gold

Updated Category News Views 168

Amaroq Celebrates First Gold Pour at Nalunaq Mine Amaroq Minerals Ltd. (NASDAQ Iceland: AMRQ), an independent mining firm, is thrilled to announce a key milestone in its operational journey. On a significant day, the company successfully completed its initial gold pour at the Nalunaq gold mine, located in the pristine region of Southern Greenland. This achievement...

Continue Reading
Deako Celebrates Two Years on Inc. 5000 Fastest Growing List

Updated Category News Views 282

Deako Triumphs as a Fast-Growing Innovator in Smart Lighting Today, the innovative company Deako has been recognized as one of America's fastest-growing private companies for the second consecutive year by the esteemed Inc. 5000 list. This notable achievement speaks volumes about Deako's commitment to growth and innovation in the realm of smart lighting solutions....

Continue Reading
Unlocking Insights: ALK’s 2024 Annual Report Presentation

Updated Category News Views 174

Join ALK for their Annual Report Presentation ALK (ALKB:DC / OMX: ALK B / AKBLF) is excited to announce the upcoming publication of its annual report for 2024, scheduled for release in the early morning. Following this, the company will conduct a presentation tailored for investors and analysts. Presentation Details This engaging session will take place in the afternoon,...

Continue Reading
AIRE Radio Networks Welcomes El Show de Raúl Brindis

Updated Category News Views 448

AIRE Radio Networks Welcomes El Show de Raúl Brindis In an exciting development for the Hispanic media landscape, AIRE Radio Networks has announced the syndication of El Show de Raúl Brindis. This show has long been a staple in the morning routines of listeners who appreciate its unique blend of humor, music, and relatable stories. Raúl Brindis has built a reputation...

Continue Reading